Retrieve available abstracts of 23 articles: HTML format
Single Articles
April 2025
KUSAMURA S, Cinquini M, Morris D, Piso P, et al Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the
Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for
Evidence Evaluation and Recommendation.
J Surg Oncol. 2025;131:810-815. PubMedAbstract available
March 2025
SONODA D, Maruyama R, Kondo Y, Mitsuhashi S, et al Clinical Course After Radical Local Therapy for Oligo-Recurrence of Nonsmall Cell
Lung Cancer.
J Surg Oncol. 2025 Mar 30. doi: 10.1002/jso.28032. PubMedAbstract available
JIMENEZ M, Flandes J, van der Heijden EHFM, Ng CSH, et al Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage
Non-Small Cell Lung Cancer Prior to Surgical Resection.
J Surg Oncol. 2025 Mar 28. doi: 10.1002/jso.28110. PubMedAbstract available
February 2025
DRIGOTAS C, Loftus AW, Ammori JB, Rothermel LD, et al Perfusion Strategies for Cytoreductive Surgery With Heated Intraperitoneal
Chemotherapy for Malignant Peritoneal Mesothelioma.
J Surg Oncol. 2025;131:310-315. PubMedAbstract available
January 2025
FENG Y, Feng H, Ye J Economic Toxicity Associated With Cancer Treatments: Commentary on "Relationship
of Surgical Approach With Financial Toxicity in Patients With Resected Lung
Cancer".
J Surg Oncol. 2025 Jan 8. doi: 10.1002/jso.28040. PubMed
December 2024
WOO W, Park B, Ahadi A, Chung LI, et al The Role of Pulmonary Metastasectomy for Non-Primary Lung Cancer: Umbrella Review
of Meta-Analyses.
J Surg Oncol. 2024 Dec 15. doi: 10.1002/jso.28033. PubMedAbstract available
DEBOEVER N, Eisenberg M, Niu J, Graber W, et al Conditional Survival of Patients With Early-Stage Non-Small Cell Lung Cancer Who
Undergo Lobectomy, Segmentectomy, or Wedge Resection Using the NCDB.
J Surg Oncol. 2024 Dec 5. doi: 10.1002/jso.27907. PubMedAbstract available
November 2024
SU YD, Ma R, Fu YB, Wu HL, et al Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma.
J Surg Oncol. 2024;130:1225-1234. PubMedAbstract available
October 2024
VITELLO DJ, Logan CD, Zaza NN, Bates KR, et al Comparison of a Risk Calculator With Frailty Indices in Patients Undergoing Lung
Cancer Resection.
J Surg Oncol. 2024 Oct 10. doi: 10.1002/jso.27861. PubMedAbstract available
NAKAO M, Suzuki A, Ichinose J, Matsuura Y, et al Risk of Death From Other Diseases in Lung Cancer Patients After Sublobar
Resection Versus Lobectomy.
J Surg Oncol. 2024 Oct 2. doi: 10.1002/jso.27927. PubMedAbstract available
September 2024
SCHIAVON M, Cannone G, Bertolaccini L, Gallina FT, et al Safety and Efficacy of Salvage Surgery after Treatment With Immune-Checkpoint
Adjuvant Inhibitors for Advanced Non-Small Cell Lung Cancer: A Multicentric
Study.
J Surg Oncol. 2024 Sep 24. doi: 10.1002/jso.27920. PubMedAbstract available
DEBOEVER N, Eisenberg MA, Antonoff MB, Hofstetter WL, et al Relationship of Surgical Approach With Financial Toxicity in Patients With
Resected Lung Cancer.
J Surg Oncol. 2024 Sep 10. doi: 10.1002/jso.27870. PubMedAbstract available
SONG KJ, Faith I, Tuminello S, Taioli E, et al Patients With Surgically Resectable Lung Cancer Who Opt for Radiation Have Worse
Outcomes.
J Surg Oncol. 2024 Sep 10. doi: 10.1002/jso.27873. PubMedAbstract available
LIANG XL, Li XB, Fu YB, Su YD, et al Research progress of malignant peritoneal mesothelioma with paraneoplastic
syndrome: A review.
J Surg Oncol. 2024;130:533-542. PubMedAbstract available
DE ALMEIDA DPA, Malta MFB, Cardoso WM, Leite ALDS, et al Metastatic benign leiomyoma: A case report of an uncommon presentation.
J Surg Oncol. 2024;130:951-954. PubMedAbstract available
August 2024
VITELLO DJ, Logan CD, Zaza NN, Bates KR, et al Comparison of a risk calculator with frailty indices in patients undergoing lung
cancer resection.
J Surg Oncol. 2024 Aug 29. doi: 10.1002/jso.27815. PubMedAbstract available
July 2024
FILHO GVM, Costa GJ, Martins MR, Torres LC, et al Circulating levels of galectin-9 are a potential biomarker of survival in
advanced non-small-cell lung cancer.
J Surg Oncol. 2024 Jul 24. doi: 10.1002/jso.27758. PubMedAbstract available
MAMEDE I, Ribeiro L, Stecca C, Escalante-Romero L, et al Survival and pulmonary function in stage IA non-small cell lung cancer after
sublobar resection versus lobectomy: An updated meta-analysis.
J Surg Oncol. 2024 Jul 9. doi: 10.1002/jso.27767. PubMedAbstract available
PORTO DM, Costa GJ, Torres LC, Casarini DE, et al Immune checkpoint expression as prognostic biomarker candidates in non-small cell
lung carcinoma patients.
J Surg Oncol. 2024 Jul 7. doi: 10.1002/jso.27763. PubMedAbstract available
March 2024
SAIKIA J, Malik PS, Kumar S, Jain D, et al Can cell-free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic
biomarker among surgically treated Stage I-III a nonsmall cell lung cancer
(NSCLC)? A pilot study.
J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27610. PubMedAbstract available
January 2024
PEZESHKIAN F, McAllister M, Singh A, Theeuwen H, et al What's new in thoracic oncology.
J Surg Oncol. 2024;129:128-137. PubMedAbstract available
December 2023
GUPTA S, Wells SL, Jose AM, Seitter RH, et al High-dose IV magnesium in mesothelioma patients receiving surgery with
hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II
randomized clinical trial.
J Surg Oncol. 2023;128:1141-1149. PubMedAbstract available
October 2023
DEBOEVER N, Bayley EM, Eisenberg MA, Hofstetter WL, et al Do resected colorectal cancer patients need early chest imaging? Impact of
clinicopathologic characteristics on time to development of pulmonary metastases.
J Surg Oncol. 2023 Oct 24. doi: 10.1002/jso.27490. PubMedAbstract available